The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Role of consolidative radiotherapy for metastatic urothelial bladder cancer patients without progression and with no more than five residual metastatic lesions following first line systemic therapy: A retrospective analysis.
 
Amélie Aboudaram
No Relationships to Disclose
 
Leonor Chaltiel
No Relationships to Disclose
 
Damien Pouessel
Honoraria - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Ipsen; Janssen Oncology; Merck
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Janssen Oncology; Pfizer; Sanofi
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Incyte (Inst); Janssen Oncology (Inst); Merck Sharp & Dohme (Inst); Roche (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Janssen Oncology; Pfizer
 
Pierre Graff-Cailleaud
No Relationships to Disclose
 
Nicolas Benziane
No Relationships to Disclose
 
Paul Sargos
No Relationships to Disclose
 
Ulrike Schick
No Relationships to Disclose
 
Gilles Crehange
No Relationships to Disclose
 
Loic Mourey
Honoraria - Amgen; Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Ipsen; Janssen; Pfizer; Sanofi
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; janssen; Pfizer; Sanofi
 
Jean-Pierre Delord
No Relationships to Disclose
 
Elizabeth Moyal
No Relationships to Disclose
 
Christine Chevreau
No Relationships to Disclose
 
Jonathan Khalifa
No Relationships to Disclose